HealthEquity Director Robert Selander Receives 2,877 Restricted Stock Units

This Form 4 filing reports that Robert W. Selander, a director of HealthEquity, Inc., received 2,877 restricted stock units (RSUs) on June 25, 2026. The RSUs were granted at $0 per share and represent a contingent right to receive shares of the company's common stock. The units will vest in full on the earlier of June 25, 2027, or the date of the company's next annual stockholder meeting in June 2027. Following this transaction, Selander's total holdings in HealthEquity common stock increased to 89,849 shares. The filing notes that Selander's power of attorney was previously filed with the SEC in June 2023. This transaction represents equity compensation for Selander's service as a director of the company.